April 22: The Week in Cancer News
Study finds a connection between bacteria and fast-growing prostate cancer, and researchers measure underrepresentation of Black patients in clinical...
Progress Against Cancer
Study finds a connection between bacteria and fast-growing prostate cancer, and researchers measure underrepresentation of Black patients in clinical...
A symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some...
Researchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but...
DNA sequencing found that in many cases when DCIS recurred, the lesion was unrelated to the first diagnosis, raising...
An AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.
Experts discuss shortcomings of current COVID-19 vaccines in people with cancer while highlighting possibilities of T-cell activation.
From the AACR Annual Meeting, “practice changing” immunotherapy effective against lung cancer, and CAR T-cell therapy targets solid tumors.
Excitement and emotion ran high Sunday morning as Margaret Foti, PhD, MD (hc), chief executive officer of the American...
CAR T-cell therapy approved for relapsed large B-cell lymphoma, and screening catches lung cancer earlier, although disparities persist